- Home
- XTNT vs INMB Comparison
XTNT vs INMB Comparison
Compare XTNT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XTNT | INMB |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.7M | 64.7M |
| IPO Year | 2009 | 2018 |
Fundamental Metrics
Financial Performance| Metric | XTNT | INMB |
|---|---|---|
| Price | $0.32 | $2.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $1.00 | ★ $5.40 |
| AVG Volume (30 Days) | ★ 2.9M | 327.1K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,337,000.00 | $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.27 | $1.09 |
| 52 Week High | $0.95 | $2.60 |
Technical Indicators
Market Signals| Indicator | XTNT | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 49.48 |
| Support Level | $0.27 | $2.21 |
| Resistance Level | $0.47 | $2.23 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 4.60 | 16.76 |
Price Performance
Historical ComparisonAbout XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.